Randomized Trial: Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
2 Nov, 2018 | 02:30h | UTCIntravenous Iron in Patients Undergoing Maintenance Hemodialysis – New England Journal of Medicine (free)
“Proactive administration of high-dose iv iron did not adversely affect mortality or CV events, but enabled reduced erythropoiesis-stimulating agent dosing and transfusion rates.” (via @NatRevNeph see Tweet)